You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 18, November 9, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Otolaryngology/ Head & Neck Surgery
 •Pediatric Otolaryngology
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Appropriate Use of Antimicrobial Drugs

A Better Prescription Is Needed

J. Todd Weber, MD

JAMA. 2005;294:2354-2356.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The problem of antimicrobial resistance has been evident almost from the time antimicrobial drugs entered the pharmacopoeia. However, the clinical impact of resistance has been difficult to measure for a variety of reasons, including separating out the effect of underlying illness and the availability of at least 1 effective drug for most infections. Antimicrobial resistance also has economic consequences, but even those have been difficult to quantify.1 Nevertheless, the decrease in new drug development and increasing resistance to multiple drug classes among various infections require effective interventions now to mitigate the inevitable increase in morbidity and mortality.

Recognizing the potential for serious consequences of resistance to antimicrobial drugs, medical societies, health plans, and insurers, as well as local, state, and federal government agencies, have conducted education and media campaigns to improve use of antimicrobials, with the intent of reducing the evolutionary pressure toward proliferation of resistant . . . [Full Text of this Article]

Author Affiliations: Office of Antimicrobial Resistance, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Ga.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLES

Clinical Decision Support and Appropriateness of Antimicrobial Prescribing: A Randomized Trial
Matthew H. Samore, Kim Bateman, Stephen C. Alder, Elizabeth Hannah, Sharon Donnelly, Gregory J. Stoddard, Bassam Haddadin, Michael A. Rubin, Jacquelyn Williamson, Barry Stults, Randall Rupper, and Kurt Stevenson
JAMA. 2005;294(18):2305-2314.
ABSTRACT | FULL TEXT  

Antibiotic Treatment of Children With Sore Throat
Jeffrey A. Linder, David W. Bates, Grace M. Lee, and Jonathan A. Finkelstein
JAMA. 2005;294(18):2315-2322.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Performance of a Rapid Antigen-Detection Test and Throat Culture in Community Pediatric Offices: Implications for Management of Pharyngitis
Tanz et al.
Pediatrics 2009;123:437-444.
ABSTRACT | FULL TEXT  

What's new in the other general journals
Tonks
BMJ 2005;331:1165-1166.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.